ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 591,23
0,28%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. MannKind Corporation (MNKD)

  7. MannKind Corporation (MNKD) Actualités

MNKD MannKind Corporation

4,23
0,05 (1,20%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
MannKind Corporation MNKD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 1,20% 4,23 06:00:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,20 4,15 4,365 4,23 4,18
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/4/202412:00GLOBEMannKind Repays Certain Debt Obligations
26/3/202421:05GLOBEMannKind Announces CFO Transition
11/3/202411:05GLOBEINHALE-3 Study’s Initial Meal Challenge Results Comparing..
05/3/202412:05GLOBEMannKind Announces New Clinical Data From Inhale-3 Study to..
04/3/202419:01GLOBEMannKind Corporation Announces Participation at Upcoming..
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:00GLOBEMannKind Corporation Reports 2023 Fourth Quarter and Full..
20/2/202412:00GLOBEMannKind Corporation to Hold 2023 Fourth Quarter and Full..
15/2/202412:05GLOBEMannKind Announces Enrollment Goal Completion of INHALE-1..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202412:06EDGAR2Form 8-K - Current report
02/1/202412:05GLOBEMannKind and Sagard Healthcare Enter Into Royalty Purchase..
28/12/202312:00GLOBEMannKind Corporation to Present at 42nd Annual J.P. Morgan..
27/12/202322:15EDGAR2Form 8-K - Current report
16/12/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:09EDGAR2Form 144 - Report of proposed sale of securities
15/12/202301:56EDGAR2Form 144 - Report of proposed sale of securities
14/12/202322:08EDGAR2Form 144 - Report of proposed sale of securities
07/11/202322:05EDGAR2Form 8-K - Current report
07/11/202322:00GLOBEMannKind Corporation Reports 2023 Third Quarter Financial..
06/11/202312:15GLOBEMannKind Announces Completion of Enrollment in U.S. Phase 4..
03/11/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202300:07EDGAR2Form 144 - Report of proposed sale of securities
31/10/202321:00GLOBEMannKind Corporation to Hold 2023 Third Quarter Financial..
30/10/202311:15GLOBEMannKind Expands Patent Portfolio With New Clofazimine..
04/10/202303:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
03/10/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202323:51EDGAR2Form 144 - Report of proposed sale of securities
06/9/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202312:00GLOBEMannKind Corporation Announces Participation at Upcoming..
01/9/202322:11EDGAR2Form 144 - Report of proposed sale of securities
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202300:45EDGAR2Form 144 - Report of proposed sale of securities
23/8/202322:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202322:06EDGAR2Form 8-K - Current report
07/8/202322:00GLOBEMannKind Corporation Reports 2023 Second Quarter Financial..
02/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202300:30EDGAR2Form 144 - Report of proposed sale of securities
01/8/202312:00GLOBEMannKind Corporation Announces Participation in the 2023..
31/7/202322:00GLOBEMannKind Corporation to Hold 2023 Second Quarter Financial..
05/7/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202312:05GLOBEMannKind Launches Inhale-3 Study to Address the Most..

Dernières Valeurs Consultées

NASDAQ
MNKD
MannKind
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés